Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Melanotan II: Evidence Summary
Evidence summary for Melanotan II across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Melanotan II overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Sexual dysfunction (erectile) | Tier C | 3 | MC4R activation produces erectogenic effects; some clinical evidence in ED patients |
| Skin tanning | Tier D | 2 | Increases melanogenesis but safety concerns limit clinical utility; not approved |